NeoPhotonics Corporation (NPTN) Fundamental Analysis & Valuation

NYSE:NPTN • US64051T1007

Current stock price

16.01 USD
+0.01 (+0.06%)
At close:
16.01 USD
0 (0%)
After Hours:

This NPTN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NPTN Profitability Analysis

1.1 Basic Checks

  • NPTN had negative earnings in the past year.
NPTN Yearly Net Income VS EBIT VS OCF VS FCFNPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -10.28%
ROE N/A
ROIC -8.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPTN Yearly ROA, ROE, ROICNPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -5 -10 -15 -20 -25

1.3 Margins

Industry RankSector Rank
OM -7.62%
PM (TTM) -10.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NPTN Yearly Profit, Operating, Gross MarginsNPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 10 -10 20

2

2. NPTN Health Analysis

2.1 Basic Checks

  • NPTN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NPTN has been increased compared to 1 year ago.
  • Compared to 1 year ago, NPTN has a worse debt to assets ratio.
NPTN Yearly Shares OutstandingNPTN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
NPTN Yearly Total Debt VS Total AssetsNPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 2.22 indicates that NPTN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • NPTN has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC-0.84
WACC10.11%
NPTN Yearly LT Debt VS Equity VS FCFNPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 2.57 indicates that NPTN has no problem at all paying its short term obligations.
  • NPTN has a Quick Ratio of 1.95. This is a normal value and indicates that NPTN is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.95
NPTN Yearly Current Assets VS Current LiabilitesNPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

4

3. NPTN Growth Analysis

3.1 Past

  • The earnings per share for NPTN have decreased strongly by -1050.00% in the last year.
  • The Revenue has decreased by -4.80% in the past year.
  • NPTN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.74% yearly.
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 72.02% on average over the next years. This is a very strong growth
  • NPTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.89% yearly.
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NPTN Yearly Revenue VS EstimatesNPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NPTN Yearly EPS VS EstimatesNPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

2

4. NPTN Valuation Analysis

4.1 Price/Earnings Ratio

  • NPTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 20.00 indicates a rather expensive valuation of NPTN.
  • NPTN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.67.
Industry RankSector Rank
PE N/A
Fwd PE 20
NPTN Price Earnings VS Forward Price EarningsNPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -266.15
NPTN Per share dataNPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • NPTN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as NPTN's earnings are expected to grow with 77.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.65%
EPS Next 3Y77.09%

0

5. NPTN Dividend Analysis

5.1 Amount

  • No dividends for NPTN!.
Industry RankSector Rank
Dividend Yield N/A

NPTN Fundamentals: All Metrics, Ratios and Statistics

NeoPhotonics Corporation

NYSE:NPTN (8/2/2022, 8:24:07 PM)

After market: 16.01 0 (0%)

16.01

+0.01 (+0.06%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05
Earnings (Next)11-02
Inst Owners1.01%
Inst Owner Change0%
Ins Owners18.64%
Ins Owner Change0%
Market Cap859.58M
Revenue(TTM)318.63M
Net Income(TTM)-33.33M
Analysts74.55
Price Target15.81 (-1.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20
P/S 2.7
P/FCF N/A
P/OCF N/A
P/B 5.67
P/tB N/A
EV/EBITDA -266.15
EPS(TTM)-0.23
EYN/A
EPS(NY)0.8
Fwd EY5%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.93
BVpS2.82
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.28%
ROE N/A
ROCE N/A
ROIC -8.46%
ROICexc N/A
ROICexgc -8.53%
OM -7.62%
PM (TTM) -10.46%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 1.95
Altman-Z 2.22
F-Score1
WACC10.11%
ROIC/WACC-0.84
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NeoPhotonics Corporation / NPTN Fundamental Analysis FAQ

What is the fundamental rating for NPTN stock?

ChartMill assigns a fundamental rating of 2 / 10 to NPTN.


What is the valuation status for NPTN stock?

ChartMill assigns a valuation rating of 3 / 10 to NeoPhotonics Corporation (NPTN). This can be considered as Overvalued.


How profitable is NeoPhotonics Corporation (NPTN) stock?

NeoPhotonics Corporation (NPTN) has a profitability rating of 0 / 10.